📣 VC round data is live. Check it out!
- Public Comps
- Joint
Joint Valuation Multiples
Discover revenue and EBITDA valuation multiples for Joint and similar public comparables like Eureka Group Holdings, Radius Residential, DocGo, Biote and more.
Joint Overview
About Joint
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company’s franchise license, which represents symbolic intellectual property.
Founded
2010
HQ

Employees
736
Website
Sectors
Financials (LTM)
EV
$109M
Valuation Multiples
Start free trialJoint Financials
Joint reported last 12-month revenue of $57M and EBITDA of $13M.
In the same LTM period, Joint generated $46M in gross profit, $13M in EBITDA, and $2M in net income.
Revenue (LTM)
Joint P&L
In the most recent fiscal year, Joint reported revenue of $55M and EBITDA of $13M.
Joint is profitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 24%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Joint Stock Performance
Joint has current market cap of $128M, and enterprise value of $109M.
Market Cap Evolution
Joint's stock price is $8.95.
Joint share price increased by 0.3% in the last 30 days, and decreased by 16.4% in the last year.
Joint has an EPS (earnings per share) of $0.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $109M | $128M | 0.0% | 0.3% | -3.2% | -16.4% | $0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJoint Valuation Multiples
Joint trades at 1.9x EV/Revenue multiple, and 8.7x EV/EBITDA.
EV / Revenue (LTM)
Joint Financial Valuation Multiples
As of May 27, 2026, Joint has market cap of $128M and EV of $109M.
Joint has a P/E ratio of 59.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Joint Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Joint Margins & Growth Rates
Joint grew revenue by 10% but EBITDA decreased by 8% in the last fiscal year.
In the most recent fiscal year, Joint reported gross margin of 80%, EBITDA margin of 24%, and net margin of 5%.
Joint Margins
Joint Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Joint Operational KPIs
Joint's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Joint's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Joint's Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Joint Competitors
Joint competitors include Eureka Group Holdings, Radius Residential, DocGo, Biote, P3 Health Partners, Third Age Health Services, Maternus-Kliniken, Oceania Healthcare, Propel Funeral Partners and LNA Sante.
Most Joint public comparables operate across Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 7.9x | 7.2x | 10.8x | 18.0x | |||
| 1.8x | 1.5x | 10.4x | 8.7x | |||
| 0.2x | 0.2x | (1.9x) | (2.6x) | |||
| 0.9x | 0.9x | 3.1x | 3.5x | |||
| 0.2x | 0.2x | (2.3x) | (4.4x) | |||
| 2.6x | - | 11.1x | - | |||
| 1.7x | - | 18.6x | - | |||
| 4.4x | 3.3x | 16.8x | 16.6x | |||
This data is available for Pro users. Sign up to see all Joint competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Joint
| When was Joint founded? | Joint was founded in 2010. |
| Where is Joint headquartered? | Joint is headquartered in United States. |
| How many employees does Joint have? | As of today, Joint has over 736 employees. |
| Who is the CEO of Joint? | Joint's CEO is Sanjiv Kumar Razdan. |
| Is Joint publicly listed? | Yes, Joint is a public company listed on Nasdaq. |
| What is the stock symbol of Joint? | Joint trades under JYNT ticker. |
| When did Joint go public? | Joint went public in 2014. |
| Who are competitors of Joint? | Joint main competitors include Eureka Group Holdings, Radius Residential, DocGo, Biote, P3 Health Partners, Third Age Health Services, Maternus-Kliniken, Oceania Healthcare, Propel Funeral Partners, LNA Sante. |
| What is the current market cap of Joint? | Joint's current market cap is $128M. |
| What is the current revenue of Joint? | Joint's last 12 months revenue is $57M. |
| What is the current revenue growth of Joint? | Joint revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Joint? | Current revenue multiple of Joint is 1.9x. |
| What is the current EBITDA of Joint? | Joint's last 12 months EBITDA is $13M. |
| What is Joint's EBITDA margin? | Joint's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Joint? | Current EBITDA multiple of Joint is 8.7x. |
| What is the current FCF of Joint? | Joint's last 12 months FCF is $4M. |
| What is Joint's FCF margin? | Joint's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Joint? | Current FCF multiple of Joint is 26.6x. |
| How many companies Joint has acquired to date? | Joint hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Joint has invested to date? | Joint hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Joint
Lists including Joint
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.